Auxiliadora Gómez

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Alfredo Carrato, Albert Abad, Bartomeu Massutí et al. · European Journal of Cancer · 2017 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

Ramón Salazar, Jaume Capdevila, Berta Laquente et al. · BMC Cancer · 2015 · 51 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab

Javier Sastre, Marta Vidaurreta, Auxiliadora Gómez et al. · Clinical Colorectal Cancer · 2013 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +17

Optimization of <i>RAS/BRAF</i> Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer

Cristina Santos, Daniel Azuara, Rocio García‐Carbonero et al. · Molecular Cancer Therapeutics · 2017 · 22 citations

Medicine, Molecular Medicine, Oncology +17

Oxaliplatin in Combination With Infusional 5-Fluorouracil as First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumors

Manuel Benavides, Carles Pericay, Manuel Valladares‐Ayerbes et al. · Clinical Colorectal Cancer · 2012 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +11